2007, Clinical Pharmacology and Pharmacokinetics

Analysis Life Sciences Thank You FDA’s nonprescription advisors find no efficacy for phenylephrine

Agency IQ

SEPTEMBER 15, 2023

In 2007, an FDA advisory committee weighed phenylephrine’s GRASE status, prompted by a Citizen Petition questioning its effectiveness In December 2007, the FDA’s Nonprescription Drugs Advisory Committee met to discuss the efficacy of phenylephrine 10 mg , the oral dosage approved for OTC use.

Science

Science FDA Clinical Trials Clinical Pharmacology

Landiolol

New Drug Approvals

APRIL 19, 2025

“Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias” Clinical Pharmacology and Therapeutics. The resulting Landiolol hydrochloride 2 has very high enantiomeric purity. PMID 27092187. Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, et al.

FDA

FDA Clinical Trials Treatment Trials

Drug Discovery Digest

Analysis Life Sciences Thank You FDA’s nonprescription advisors find no efficacy for phenylephrine

Landiolol

Webinars

Stay Connected